The invention provides SPARC and Albumin binding peptides for the targeting of disease sites, such as tumors, with therapeutic and diagnostic agents. In particular, compositions comprising SPARC binding peptide ~ Antibody Fc domain fusion proteins and methods of their use are disclosed.